No. 921New York · London · SingaporeUpdated July 22, 2026

Financial News
& Market Press Releases

MARKETSNVO, LLY: Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss drug rivalryJul 22MARKETSGE Vernova in focus as EPS miss sends shares down more than 7%Jul 22BABAE Systems, Boeing, and Saab form UK pilot training partnership around the T-7Jul 22GMGM CFO Says Rising Gasoline Prices Have Not Weighed on Vehicle SalesJul 22GMGM raises full-year guidance a second time as results top analyst expectationsJul 22LLYLLY advertising defense in focus as Novo Nordisk lawsuit continuesJul 22MARKETSCME Group (NASDAQ: CME) posts $1.7 billion in Q2 2026 revenue as net income reaches $1.0 billionJul 22SMCISMCI in focus for Tuesday after-hours session alongside Capital One Financial, Chubb, and PegasystemsJul 22MARKETSUS Treasury flags 'tax alpha' strategies, AMG shares in focusJul 22MARKETSOpenAI names two financial executives to nonprofit and for-profit boardsJul 22MARKETSNVO, LLY: Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss drug rivalryJul 22MARKETSGE Vernova in focus as EPS miss sends shares down more than 7%Jul 22BABAE Systems, Boeing, and Saab form UK pilot training partnership around the T-7Jul 22GMGM CFO Says Rising Gasoline Prices Have Not Weighed on Vehicle SalesJul 22GMGM raises full-year guidance a second time as results top analyst expectationsJul 22LLYLLY advertising defense in focus as Novo Nordisk lawsuit continuesJul 22MARKETSCME Group (NASDAQ: CME) posts $1.7 billion in Q2 2026 revenue as net income reaches $1.0 billionJul 22SMCISMCI in focus for Tuesday after-hours session alongside Capital One Financial, Chubb, and PegasystemsJul 22MARKETSUS Treasury flags 'tax alpha' strategies, AMG shares in focusJul 22MARKETSOpenAI names two financial executives to nonprofit and for-profit boardsJul 22

NewsMacro

GE Vernova in focus as EPS miss sends shares down more than 7%

GE Vernova (GEV) is in focus after an earnings miss sent shares lower by more than 7% in the session. The Club, which holds the stock, calls that reaction short-sighted. Its argument rests on demand, a variable the session move appears to have discounted entirely.

By Tomas ReyesMacro DeskJuly 22, 20262 min read

GE Vernova (GEV) shares fell more than 7% in the session after an EPS miss.
The Club, which holds the stock, called the sell-off short-sighted, arguing investors weighted the wrong variable.
The Club's core counterpoint is strong demand, which it frames as the forward-looking input that matters more than a closed-period earnings miss.
The next confirmable data point is any guidance or filing in which GE Vernova speaks directly to its demand outlook.
Whether the stock reverses the drop depends on whether the company confirms the demand picture the Club points to.

The print and the tape's answer

The catalyst is an EPS miss. More than 7% came off the stock in response, a single-session move that tends to reset the thesis conversation. The tape's answer was to sell. The Club's answer is that the tape is looking at the wrong line.

The demand argument

The Club's counterpoint is strong demand. Earnings can diverge from the underlying demand picture in the short run, and its position is that investors who sold on the miss weighted the wrong variable. Short-sighted is the word it uses. That framing implies the demand data was there to be read alongside the EPS print. Sellers chose not to weight it.

Demand is the forward-looking input. An earnings miss reflects a period already closed. The Club is making the case that the former matters more to the setup than the latter.

What to watch

The next confirmable data point is any guidance or filing in which GE Vernova speaks directly to its demand outlook. A session drop of more than 7% has done real work repricing the stock. Whether the tape reverses that work depends on whether the company confirms the demand picture the Club is pointing to. That disclosure is the milestone the setup turns on.

More from the Newsroom

All stories →

01Macro

NVO, LLY: Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss drug rivalry

The weight-loss drug rivalry between Novo Nordisk and Eli Lilly is in focus for NVO and LLY holders after Novo Nordisk accused Lilly of deploying outdated data to support claims that Lilly's products are more effective than Wegovy. The Danish company's framing is direct: the cond

Owen Gallagher2 min read

02Macro · BA

BAE Systems, Boeing, and Saab form UK pilot training partnership around the T-7

A three-way arrangement between BAE Systems, Boeing (BA), and Saab centers the Boeing T-7 system as the platform for expanded pilot training options in the United Kingdom. The parties have not disclosed a contract value, timeline, or unit commitment alongside the announcement. Wh

Mateo Fuentes2 min read

03Macro · GM

GM CFO Says Rising Gasoline Prices Have Not Weighed on Vehicle Sales

In focus for General Motors (GM) is a direct assertion from the company's chief financial officer that elevated gasoline prices have not impacted vehicle sales. The statement is the company's own read on consumer demand, and it arrives without accompanying sales figures in the so

Jonah Berg2 min read

Frequently asked

Why did GE Vernova's stock drop?

The stock fell more than 7% in the session in response to an EPS (earnings per share) miss.

Why does the Club think the sell-off was short-sighted?

The Club argues that sellers weighted the earnings miss over strong demand, and that demand is the forward-looking input that matters more to the setup than a period already closed.

What should investors watch next?

The key milestone is any guidance or filing in which GE Vernova speaks directly to its demand outlook, which would confirm or undercut the Club's thesis.

How much of the move did the earnings miss cause?

The EPS miss triggered a single-session decline of more than 7% in GE Vernova shares.